KENYON LAWRENCE A - Insider Non-Derivative Transactions at Outlook Therapeutics, Inc. (OTLK) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 26, 2024, KENYON LAWRENCE A's relationship to Outlook Therapeutics, Inc. (OTLK) is Director,Officer (Chief Financial Officer), and currently has 5,946 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other OTLK insiders.
Data Source: SEC.
KENYON LAWRENCE A - Insider Non-Derivative Transactions at OTLK
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 27, 2024 | P -- (Common Stock) | 5000 | 5.69 | 5946 |